| Title： | √Assessment and Management of Antinuclear Antibodies positive population |
| Edition： | Original |
| Classification： | Patient version of guideline |
| Field： | |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | GRADE |
| Development unit： | Guangdong Provincial Clinical Research Center for Immunological Diseases |
| Registration time: | 2020-09-11 |
| Registration number： | IPGRP-2020CN158 |
| Purpose of the guideline: |
